CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

Why is it important to assess cognition in criminal cases?

Dr Seán Haldane is a Consultant Neuropsychologist and expert witness who provides reports for defence lawyers, the Crown Prosecution Service and the police. We caught up with Dr Haldane to discuss how CANTAB Insight is integral to his work.  

CANTAB tests predict functional decline in patients with amnestic mild cognitive impairment

We presented a novel, predictive model of functional decline at CTAD 2018. The model suggests that CANTAB PAL and SWM provide essential screening information when recruiting patients with amnestic mild cognitive impairment into Alzheimer’s disease clinical trials.

How do acute, subacute and repeated exposures to high altitude affect cognition?

We caught up with University of Calgary Postdoctoral Research Fellows, Dr Matiram Pun and Dr Veronica Guadagni, to discuss the role of CANTAB in their recent research paper on how different exposures to high altitude affect cognitive function.

How easy is it to transition your study onto the CANTAB Connect platform?

We caught up with Shinwon Park at Ewha Womens University to discuss their experiences of updating their longitudinal studies from tablet-only CANTAB Eclipse to the cloud-based CANTAB Connect Research platform. 

Using CANTAB to investigate age-related cognitive changes associated with dementia in Down syndrome

PhD researcher, Rosalyn Hithersay, spoke to us about her recent publication on which cognitive tests are most sensitive to the early stages of dementia in Down syndrome.

New product to improve workplace mental health

We are very pleased to announce a planned new software product to assess mental health and wellbeing at work, CANTAB BrainHealth™.

7 tests for assessing cognition in early Alzheimer’s disease

With rising life-expectancy, the number of cases of dementia and related disorders is increasing. In attempts to tackle the pandemic, treatment trials are moving earlier in the disease process. CANTAB offers a battery of tests specially targeted at assessing cognition in early Alzheimer’s disease (AD), and the associated effects on cognition with drug action

6 cognitive tests for research of depression and mood disorders

Mood disorders affect 5-10% of the adult population in a given year. The most common mood disorders are major depressive disorder, dysthymia, and bipolar disorder. Here we explore the six CANTAB tests for objectively measuring cognitive function in depression. 

What is cognition?

Cognition is essential for everyday functioning - here's why. 

web-based testing, wearables, voice recognition, virtual clinical trials, transdiagnostic, technology, swm, subjective measures, stigma, social cognition, smartphones, set-shifting, screening, schizophrenia research, schizophrenia, rvp, risk-taking, research funding, research, remote testing, regulations, recruitment, prodromal, pro-cognitive, primary care, presenteeism, precision psychiatry, pre-clinical, personalised medicine, pen-and-paper, patient-centric, patient screening, patient recruitment, parkinson's disease, pal, ots, open access, occupational health, objective measures, novel, normative data, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, mental wellbeing, mental health at work, mental health, mci, major depression, longitudinal, inflammation, ied, high frequency, healthcare, guide, funding, ert, epidemiology, emotion recognition, ecoa, ebt, ebbinghaus, early career researchers, early alzheimer's disease, drug development, digital tools, digital health, depression, dementia, cognitive testing, cognitive science, cognitive safety, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, cgt, cantab research grant, cantab for clinical trials, cantab, brain health, biomarkers, awards, automatic speech recognition, attention, alzheimer's disease, altitude, affective cognition, absenteeism,